Elena Marquez - 22 Sep 2025 Form 3 Insider Report for Anterix Inc. (ATEX)

Role
Chief Financial Officer
Signature
/s/ Gena L. Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
22 Sep 2025
Net transactions value
$0
Form type
3
Filing time
04 Nov 2025, 19:11:56 UTC
Next filing
04 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Marquez Elena Chief Financial Officer 3 GARRET MOUNTAIN PLAZA, SUITE 401, WOODLAND PARK /s/ Gena L. Ashe, Attorney-in-Fact 04 Nov 2025 0002090789

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATEX Common Stock 7,028 22 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATEX Stock Option (Right to Buy) 22 Sep 2025 Common Stock 3,680 $40.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes Restricted Stock Units in the amount (i) 877 shares vesting on May 15, 2026; (ii) 672 shares vesting on July 12, 2026; and (iii) 3,925 shares vesting in 3 equal annual installments beginning on October 4, 2025.
F2 The option shares vest and become exercisable in 3 equal annual installments beginning on October 4, 2025.